Skip to content

Insider · CIK 0002049601

Kevin James Craig

officer

Files at ATAI (Atai Beckley N.V.), ATAI (AtaiBeckley Inc.). First filing Mar 24, 2025, latest Jun 29, 2026.

Kevin James Craig files SEC Form 4 as officer at ATAI (AtaiBeckley Inc.), and also at ATAI (Atai Beckley N.V.). Since Mar 24, 2025, Kevin James Craig has reported 0 open-market buys worth $0 and 4 open-market sells worth $776k, the latest filed on Jun 29, 2026.

A track record needs three past buys with six months of prices behind them; Kevin James Craig has 0, so none is measured yet.

The newest scored trade: sold $192k of ATAI on Jun 25, 2026, filed Jun 29, 2026, scored 20 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 3 sells worth $760k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $776k sold

Where the trades landed

Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.

ATAI: AtaiBeckley Inc.

ATAISep 11, 2026 · close 7.35

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

ATAI: Atai Beckley N.V.

ATAISep 11, 2026 · close 7.35

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
20Weak
ATAIsell 210b5-1
AtaiBeckley Inc.
$192k
42,579 shares
-83%-
12Weak
ATAIsell10b5-1
AtaiBeckley Inc.
$213k
42,579 shares
-83%-
15Weak
ATAIsell10b5-1
AtaiBeckley Inc.
$355k
100,000 shares
-92%-
50Moderate
ATAIsell 5
Atai Beckley N.V.
$16k
11,563 shares
-58%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Mar 21, 2025 ATAI
ATAI Life Sciences N.V.
11,563
0.01% of outstanding
$16kMar 21, 2025none

Transactions

Every row this insider has filed, 29 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 11, 2026ATAI
AtaiBeckley Inc.
DDisposition to issuer
Common Stock
-8,437--032 d ago
Sep 11, 2026ATAI
AtaiBeckley Inc.
DDisposition to issuer
Stock Optionderivative
-10,000--032 d ago
Sep 11, 2026ATAI
AtaiBeckley Inc.
DDisposition to issuer
Stock Optionderivative
-50,400--032 d ago
Sep 11, 2026ATAI
AtaiBeckley Inc.
DDisposition to issuer
Stock Optionderivative
-28,608--032 d ago
Sep 11, 2026ATAI
AtaiBeckley Inc.
DDisposition to issuer
Stock Optionderivative
-372,701--032 d ago
Sep 11, 2026ATAI
AtaiBeckley Inc.
DDisposition to issuer
Stock Optionderivative
-673,808--032 d ago
Sep 11, 2026ATAI
AtaiBeckley Inc.
DDisposition to issuer
Stock Optionderivative
-675,000--032 d ago
Sep 11, 2026ATAI
AtaiBeckley Inc.
DDisposition to issuer
Restricted Stock Unitsderivative
-150,000--032 d ago
Jun 25, 2026ATAI
AtaiBeckley Inc.
MOption exercise
Common Stock10b5-1
+33,051$1.50$50k41,488Jun 29, 2026
Jun 25, 2026ATAI
AtaiBeckley Inc.
MOption exercise
Common Stock10b5-1
+9,528$1.18$11k51,016Jun 29, 2026
Jun 25, 2026ATAI
AtaiBeckley Inc.
SOpen-market sale
Common Stock10b5-1
-42,579$4.51$192k8,437Jun 29, 2026
Jun 25, 2026ATAI
AtaiBeckley Inc.
MOption exercise
Stock Optionderivative10b5-1
-33,051$0.00$0673,808Jun 29, 2026
Jun 25, 2026ATAI
AtaiBeckley Inc.
MOption exercise
Stock Optionderivative10b5-1
-9,528$0.00$028,608Jun 29, 2026
Apr 20, 2026ATAI
AtaiBeckley Inc.
MOption exercise
Common Stock10b5-1
+27,280$1.50$41k35,717Apr 22, 2026
Apr 20, 2026ATAI
AtaiBeckley Inc.
MOption exercise
Common Stock10b5-1
+15,299$1.84$28k51,016Apr 22, 2026
Apr 20, 2026ATAI
AtaiBeckley Inc.
SOpen-market sale
Common Stock10b5-1
-42,579$5.00$213k8,437Apr 22, 2026
Apr 20, 2026ATAI
AtaiBeckley Inc.
MOption exercise
Stock Optionderivative10b5-1
-27,280$0.00$0706,859Apr 22, 2026
Apr 20, 2026ATAI
AtaiBeckley Inc.
MOption exercise
Stock Optionderivative10b5-1
-15,299$0.00$0372,701Apr 22, 2026
Mar 20, 2026ATAI
AtaiBeckley Inc.
MOption exercise
Common Stock10b5-1
+76,224$1.18$90k84,661Mar 24, 2026
Mar 20, 2026ATAI
AtaiBeckley Inc.
MOption exercise
Common Stock10b5-1
+23,776$1.50$36k108,437Mar 24, 2026
Mar 20, 2026ATAI
AtaiBeckley Inc.
SOpen-market sale
Common Stock10b5-1
-100,000$3.55$355k8,437Mar 24, 2026
Mar 20, 2026ATAI
AtaiBeckley Inc.
MOption exercise
Stock Optionderivative10b5-1
-76,224$0.00$038,136Mar 24, 2026
Mar 20, 2026ATAI
AtaiBeckley Inc.
MOption exercise
Stock Optionderivative10b5-1
-23,776$0.00$0734,139Mar 24, 2026
Jan 30, 2026ATAI
AtaiBeckley Inc.
AGrant or award
Stock Optionderivative
+675,000$0.00$0675,000Feb 3, 2026
Jan 30, 2026ATAI
AtaiBeckley Inc.
AGrant or award
Restricted Stock Unitsderivative
+150,000$0.00$0150,000Feb 3, 2026
Mar 21, 2025ATAI
Atai Beckley N.V.
SOpen-market sale
Common Shares
-11,563$1.35$16k8,437Mar 24, 2025
Mar 14, 2025ATAI
Atai Beckley N.V.
MOption exercise
Common Shares
+20,000--20,000Mar 19, 2025
Mar 14, 2025ATAI
Atai Beckley N.V.
MOption exercise
Restricted Stock Unitsderivative
-20,000$0.00$00Mar 19, 2025
Mar 3, 2025ATAI
Atai Beckley N.V.
AGrant or award
Stock Optionderivative
+757,915$0.00$0757,915Mar 6, 2025

Questions about Kevin James Craig

Answered from the filings on this page, as of the latest one.

Is Kevin James Craig buying or selling?

In the last 12 months Kevin James Craig reported 0 open-market buys worth $0 and 3 open-market sells worth $760k on SEC Form 4; the latest was sold $192k of ATAI on Jun 25, 2026. Grants, option exercises and tax withholding are not counted.

How did Kevin James Craig's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kevin James Craig has 0.

Where does Kevin James Craig file Form 4?

Kevin James Craig has filed Form 4 at ATAI (AtaiBeckley Inc.) as Chief Medical Officer; ATAI (Atai Beckley N.V.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.